Trade Koninklijke Philips N.V. - PHGeur CFD

Trading Conditions

• TypeThis financial instrument is available for trading through CFDs and Knock-outs.Knock-out options available only for selected countries.Learn more about:CFDsKnock-outs:
  CFD

  

  Knock-out

  
• Spread: 0.06
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment€1,000.00Overnight funding adjustmentCharges from full value of position-0.017302 %(-€0.87)Trade size with leverage ~ €5,000.00Money from leverage ~€4,000.00Go to platform: -0.01730%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment€1,000.00Overnight funding adjustmentCharges from full value of position-0.004921 %(-€0.25)Trade size with leverage ~ €5,000.00Money from leverage ~€4,000.00Go to platform: -0.00492%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: EUR
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: Netherlands
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: €1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.017302 %
  (-€0.87)

• Margin. Your investment: €1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.004921 %
  (-€0.25)

Key Stats

• Prev. Close: 23.225
• Open: 22.785
• 1-Year Change: 7.71%
• Day's Range: 22.695 - 22.905

Trade Koninklijke Philips N.V. - PHGeur

About Koninklijke Philips NV

Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Koninklijke Philips NV revenues decreased 1% to EUR17.16B. Net income before extraordinary items decreased 39% to EUR608M. Revenues reflect Personal Health segment decrease of 37% to EUR3.41B, Connected Care and Health Informatics segment decrease of 17% to EUR4.59B, Other Countries segment decrease of 22% to EUR5.04B, Germany segment decrease of 36% to EUR839M.

Equity composition

5/2013, optional dividend in shares or cash. Exchange ratio will be announced on 04 June 2013 (Factor 1). 6/2020 Stock Dividends, adj.fac. 1.02029 (from e-mail 7/6/2020).